Mecoprop

Name: Mecoprop
Brand: SIAL
Price: 402 BRL

PESTANAL^®, analytical standard

Synonym(s):

2-(4-Chloro-2-methylphenoxy)propionic acid

Slide 1 of 1

Select a Size

100 MG

R$402.00

Check Cart for Availability

Request a Bulk Order

About This Item

Empirical Formula (Hill Notation):

C₁₀H₁₁ClO₃

CAS Number:

93-65-2

Molecular Weight:

214.65

UNSPSC Code:

41116107

NACRES:

NA.24

PubChem Substance ID:

329755294

EC Number:

202-264-4

Beilstein/REAXYS Number:

6568283

MDL number:

MFCD00002648

Key Documents

View All Documentation

Product Name

Mecoprop, PESTANAL^®, analytical standard

InChI key

WNTGYJSOUMFZEP-UHFFFAOYSA-N

InChI

1S/C10H11ClO3/c1-6-5-8(11)3-4-9(6)14-7(2)10(12)13/h3-5,7H,1-2H3,(H,12,13)

SMILES string

CC(Oc1ccc(Cl)cc1C)C(O)=O

grade

analytical standard

product line

PESTANAL^®

shelf life

limited shelf life, expiry date on the label

technique(s)

HPLC: suitable
gas chromatography (GC): suitable

application(s)

agriculture
environmental

format

neat

Quality Level

100

Looking for similar products? Visit Product Comparison Guide

Related Categories

Pesticide Standards

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item	45555	36850	45817
Supelco 36147 Mecoprop	Supelco 45555 MCPA	Supelco 36850 Fenoxaprop-P	Supelco 45817 Haloxyfop
format neat	format neat	format neat	format neat
technique(s) HPLC: suitable, gas chromatography (GC): suitable	technique(s) HPLC: suitable, gas chromatography (GC): suitable	technique(s) HPLC: suitable, gas chromatography (GC): suitable	technique(s) HPLC: suitable, gas chromatography (GC): suitable
grade analytical standard	grade analytical standard	grade analytical standard	grade analytical standard
product line PESTANAL^®	product line PESTANAL^®	product line PESTANAL^®	product line PESTANAL^®
shelf life limited shelf life, expiry date on the label	shelf life limited shelf life, expiry date on the label	shelf life limited shelf life, expiry date on the label	shelf life limited shelf life, expiry date on the label
application(s) agriculture environmental	application(s) agriculture environmental	application(s) agriculture environmental	application(s) agriculture environmental

Application

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

Legal Information

PESTANAL is a registered trademark of Merck KGaA, Darmstadt, Germany

pictograms

GHS06,GHS05,GHS09

signalword

Danger

hcodes

H302,H311,H315,H318,H410

pcodes

P264 - P273 - P280 - P301 + P312 - P302 + P352 + P312 - P305 + P351 + P338

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Eye Dam. 1 - Skin Irrit. 2

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Faceshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

BCCK2521

BCCB1112

BCBV9245

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas: A Randomized Controlled Trial.

Yutaka Osuga et al.

Obstetrics and gynecology, 133(3), 423-433 (2019-02-12)

To investigate the noninferiority of relugolix compared with leuprorelin acetate in reducing heavy menstrual bleeding associated with uterine leiomyomas. In a double-blind, double-dummy trial, premenopausal women with uterine leiomyomas and heavy menstrual bleeding defined as a pictorial blood loss assessment

Uptake of 13-Valent Pneumococcal Conjugate Vaccine among US Adults Aged 19 to 64 Years with Immunocompromising Conditions.

Jeffrey Vietri et al.

Human vaccines & immunotherapeutics, 16(1), 161-168 (2019-07-26)

The CDC Advisory Committee on Immunization Practices (ACIP) recommended immunization with the recently licensed 13-valent pneumococcal conjugate vaccine (PCV13) for high-risk (immunocompromised) adults aged ≥19 years in 2012. This was in addition to the 23-valent pneumococcal polysaccharide vaccine (PPSV23). Data

Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies.

Régis Peffault de Latour et al.

British journal of haematology, 191(3), 476-485 (2020-05-26)

Ravulizumab, a novel long-acting complement component 5 (C5) inhibitor administered every 8 weeks (q8w), was non-inferior to eculizumab for all efficacy outcomes in two randomised, open-label, phase 3 trials in C5 inhibitor-naïve (Study 301) and eculizumab-experienced (Study 302) adult patients

The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer.

Julien Taieb et al.

Drugs, 79(13), 1375-1394 (2019-07-28)

The approval of targeted therapies for metastatic colorectal cancer (mCRC) has led to important improvements in patient outcomes. However, it is still necessary to increase individualisation of treatments based on tumour genetic profiles to optimise efficacy, while minimising toxicity. As

Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with

Kohei Shitara et al.

Oncotarget, 8(45), 79546-79555 (2017-11-08)

SAR125844 is a potent and selective inhibitor of the c-Met kinase receptor. This was an open-label, phase I, multicenter, dose-escalation, and dose-expansion trial of SAR125844 in Asian patients with solid tumors, a subgroup of whom had gastric cancer and

View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service